V
Verix
Verix offers innovative SaaS business analytical solutions to streamline commercial operations and optimize business processes
About Verix
Verix specializes in AI-driven analytics tailored for the pharmaceutical and consumer packaged goods (CPG) industries. The company focuses on bridging the gap between business needs and advanced analytical capabilities by embedding machine learning models into the life sciences business environment. Verix's solutions are designed to boost commercial operations with vertical solutions tailored to the specific needs of each industry. The company offers pre-packaged, agile analytic applications that utilize augmented intelligence to solve critical business process challenges, impacting ROI within months. Verix serves clients such as Ironshore Pharmaceuticals and Bayer, providing relevant and accurate dashboards that highlight leading indicators of business performance for every role in commercial operations. The business model revolves around offering industry-specific insights that help solve actual business problems, with a focus on meaningful reporting and advanced self-service capabilities. Verix makes money through the sale of its analytic applications and services, which are designed to enhance sales force effectiveness, new drug launches, prescription tracking, and market access in the life sciences sector, as well as SKU portfolio optimization, delisting, on-shelf availability optimization, and promotion responsiveness optimization in the CPG sector.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2007
- Headquarters
- Petah Tikva, Israel
- Employees
- 60
- Open positions
- None listed
- Dealroom signal
- 71.9/100
- Industry
- Enterprise Software
- Sector
- AI, Knowledge Management, Analytics, Business Intelligence, Business Management, Commerce, Streamline, Hard Tech
- Technology
- Artificial Intelligence, Machine Learning
- Business model
- SaaS
- Client focus
- b2b
- Investment activity
- 1 company, latest Jun 2023
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| CONVERTIBLE✓Equity / VC | Aug 2019 | $0 | — | Pear Ventures | — |
| SERIES B✓Equity / VC | Feb 2006 | $13M | $51M | Hillsven Capital · Viola Ventures · Gemini Israel Ventures | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Verix is 4.8K monthly website visits, up 50% over the last three months. Verix's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Hillsven Capital
Viola Ventures
Gemini Israel Ventures
Pear Ventures
Other known investors1 additional known investor
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Verix on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Verix’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.